http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Sung Ho Kyung,Kim Jin Yong,Heo Jeonghun,Seo Haesook,Jang Young soo,Kim Hyewon,Koh Bo Ram,Jo Neungsun,Oh Hong Sang,Baek Young Mi,Park Kyung-Hwa,Shon Jeung A,Kim Min-Chul,Kim Joon Ho,Chang Hyun-Ha,Park 대한의학회 2020 Journal of Korean medical science Vol.35 No.30
Background: The fatality rate of patients with coronavirus disease 2019 (COVID-19) varies among countries owing to demographics, patient comorbidities, surge capacity of healthcare systems, and the quality of medical care. We assessed the clinical outcomes of patients with COVID-19 during the first wave of the epidemic in Korea. Methods: Using a modified World Health Organization clinical record form, we obtained clinical data for 3,060 patients with COVID-19 treated at 55 hospitals in Korea. Disease severity scores were defined as: 1) no limitation of daily activities; 2) limitation of daily activities but no need for supplemental oxygen; 3) supplemental oxygen via nasal cannula; 4) supplemental oxygen via facial mask; 5) non-invasive mechanical ventilation; 6) invasive mechanical ventilation; 7) multi-organ failure or extracorporeal membrane oxygenation therapy; and 8) death. Recovery was defined as a severity score of 1 or 2, or discharge and release from isolation. Results: The median age of the patients was 43 years of age; 43.6% were male. The median time from illness onset to admission was 5 days. Of the patients with a disease severity score of 3–4 on admission, 65 (71.5%) of the 91 patients recovered, and 7 (7.7%) died due to illness by day 28. Of the patients with disease severity scores of 5–7, 7 (19.5%) of the 36 patients recovered, and 8 (22.2%) died due to illness by day 28. None of the 1,324 patients who were < 50 years of age died; in contrast, the fatality rate due to illness by day 28 was 0.5% (2/375), 0.9% (2/215), 5.8% (6/104), and 14.0% (7/50) for the patients aged 50–59, 60–69, 70–79, and ≥ 80 years of age, respectively. Conclusion: In Korea, almost all patients of < 50 years of age with COVID-19 recovered without supplemental oxygen. In patients of ≥ 50 years of age, the fatality rate increased with age, reaching 14% in patients of ≥ 80 years of age.
Apparent seed quality and climatic factors during reproductive stage in soybean
Sang-Ouk Shin,Seong-Hyu Shin,Tae-Joung Ha,Sea-Gyu Lim,Kyung-Jin Choi,In-Yeul Baek,Keum-Yong Park,Sang-Chul Lee 한국작물학회 2008 한국작물학회 학술발표대회 논문집 Vol.2008 No.10
This experiment was carried out to examine seed quality as affected by enviromental cutivation for the production of high quality domestic soybean variety at Miryang (altitude : 12m) and Muju(altitude : 600m). Variety used were Daewon, Daepung, Daol and Cheongja 3. Seeding was performed on April 30 to June 30 and planting density was 142,857 palnts/ha. Seed weight across regions was lighter as seeding date was delayed. Opposite trends between seed crack and seed weight was obtained. Seed crack decreased as seeding date was delayed and have higher occurrence in Miryang than in Muju. Perple seed and phomopsis decayed seed decreased as seeding date was delayed. There was a significant negative correlation between seed weight and mean temperature from R2 to R4 stages in all variety. Seed weight increased as mean temperature from R2 to R4 stage decreased to 22.0℃, which was greatly manifested on Daewon variety. At maturity time, Daewon variety had an average increase of 1.79g as mean temperature decreased by 1℃. Seed weight of Daewon obtained a significant negative correlation with mean temperature at R4~R6 stage and on rainfall at R4~R6 stage. Mean temperature and rainfall were able to estimate 100 seed weight of Daewon and Daepung variety with 98.1% and 96.6% probability, respectively. Phomopsis occurrence in late maturity type was closely related to rainfall during the R4~R6 stages.
Development of a Versatile Amplifier for Electrostatic Tactile Stimulation
( Sung Jun Park ),( Jung Chul Lee ),( Ji Hye Baek ),( Mi Hyun Choi ),( Hyung Sik Kim ),( Soon Cheol Chung ) 한국감성과학회 2015 추계학술대회 Vol.2015 No.-
In this study, we developed an electrostatic tactile stimulator based on audio power amplifier. This stimulator consisted of a PC, amplifier, and power unit. PC generates stimulation parameters, which are stimulus waveform, frequency and time. The amplifier amplifies stimulation signal to evoke an electrostatic sensation. The power unit converts 220 VAC to 300 VDC to supply powers to an audio power amplifier. To verify the developed stimulator, we performed human perception experiments on the index finger with electro encephalogram (EEG). Also, perception responses were recorded in range of various frequencies (5-300 Hz). From the results, activation changes with different stimulation frequencies, and the event-related potential (ERP) of all subjects were measured after stimulation. Furthermore, stimulation parameters such as stimulation waveform, strength, and time were controlled easily without additional devices. Thus, it is widely used in various tactile sensations studies.
Recurrence of Small Cerebral Aneurysms (< 4 mm) Treated Endovascularly Using Target® NanoTM Coils
Sung Min Kim,Hyun Gon Lee,Byung Sam Choi,Jung Soo Kim,Sungjoon Lee,Hae Yu Kim,Sung Tae Kim,Young-Gyun Jeong,Jin Wook Baek,Hae Woong Jeong,Sung-Chul Jin 대한뇌혈관외과학회 2018 Journal of Cerebrovascular and Endovascular Neuros Vol.20 No.2
Objective : In our series, endovascular coiling with Target® NanoTM coils (Stryker Neurovascular, Fremont, CA, USA) with diameters of 1 or 1.5 mm exhibited favorable technical feasibility in the treatment of small cerebral aneurysms (< 4 mm). However, little is known about the recurrence of small cerebral aneurysms treated using Target® NanoTM coils. We investigated recurrence following the treatment of small cerebral aneurysms using Target® NanoTM coils. Materials and Methods : Between January 2012 and November 2013, 143 patients with 148 small cerebral aneurysms (< 4 mm) were included our study. A total of 135 cerebral aneurysms (91.2%) were unruptured; 45 cerebral aneurysms (30.4%) were treated by endovascular coiling using Target® NanoTM coils. Follow-up radiological images were obtained for 132 cerebral aneurysms (89.2%) over a range of 3 to 58 months (mean, 34.3 months; standard deviation, 14.2). Results : In the group treated with Target® NanoTM coils, radiological outcomes revealed complete occlusion in 33 (73.3%), residual necks in eight (17.8%), and residual sacs in four (8.9%) cases. Follow-up radiological outcomes revealed complete occlusion in 35 (77.8%) and residual necks in four (8.9%) cases that exhibited stable coil masses. In the group that was not treated with Target® NanoTM coils, radiological outcomes revealed complete occlusion in 69 (67%), residual necks in 18 (17.5%), and residual sacs in 16 (15.5%) cases. Follow-up radiological outcomes revealed complete occlusion in 87 (84.5%) and residual necks (5.8%) in six cases that exhibited stable coil masses. No significant differences were observed in the radiological outcomes or follow-up radiological outcomes between the two groups. No recurrences or retreatments occurred in our series. Conclusion : Endovascular treatment using Target® NanoTM coils may be a robust treatment option for small cerebral aneurysms (< 4 mm).
Baek, Jong Yun,Yu, Jeong Il,Park, Hee Chul,Choi, Doo Ho,Yoo, Gyu Sang,Cho, Won Kyung,Lee, Woo-Yong,Yun, Seong Hyeon,Cho, Yong Beom,Park, Yoon Ah,Kim, Hee Cheol The Korean Society for Radiation Oncology 2019 Radiation Oncology Journal Vol.37 No.2
Purpose: This study aimed to identify prognostic factors for locoregional recurrence (LRR) in pT3N0 rectal cancer patients who were treated with surgery alone and had negative resection margin including circumferential resection margin (CRM) for optimal indication of adjuvant radiotherapy. Materials and Methods: We reviewed patients with pT3N0 rectal cancer who were treated via upfront surgery and had no other adjuvant treatment from January 2003 to December 2012. In total, 122 patients who had negative resection margin including negative CRM were included in the analysis. Results: The median follow-up period after surgery was 60 months (range, 3 to 161 months). During this time, 6 patients (4.9%) experienced LRR at the anastomotic site (4 patients), and regional lymphatic area (2 patients). The estimated 5-year rates of overall survival, recurrence-free survival, and LRR-free survival were 96.7%, 84.6%, and 94.0%, respectively. Multivariate analysis showed that level of tumor ≤5 cm was a significant prognostic factor for LRR-free survival (LRRFS) (p = 0.04; hazard ratio = 7.08; 95% confidence interval, 1.06-47.30). Patients with level of tumor ≤5 cm had an estimated 5-year LRRFS of 66.8%, which was much higher than 2.3% in patients with level of tumor >5 cm. There was no significant factor for recurrence-free survival or overall survival. Conclusion: In T3N0 rectal cancer, adjuvant chemoradiotherapy should be recommended in patients with level of tumor ≤5 cm for better local control. However, in patients with pT3N0 disease, negative resection margin, and level of tumor >5 cm, adjuvant chemoradiotherapy should be carefully suggested.
A New Large Seed Size, Good Seed Quality and High-Yielding Vegetable Soybean Cultivar "Danmiput"
Sung Taeg Kang,In Youl Baek,Myoung Gun Choung,Sea Kwan Oh,Won Young Han,Doo Chull Shin,Su Dong Kim,Soon Chul Kim 한국육종학회 2003 한국육종학회지 Vol.35 No.4
A new vegetable soybean variety, “Danmiput” was selected from the cross Keunol/Wasehakucho (Introduced), and developed in 2002 on the basis of its yield performance and seed quality for vegetable soybean at the National Yeongnam Agricultural Station. “Dan
Baek, Ahreum,Kim, Yoon,Lee, Jin Woo,Lee, Sang Chul,Cho, Sung-Rae Cognizant Communication Corp. 2018 CELL TRANSPLANTATION Vol. No.
<P>Osteoarthritis (OA) is degenerative disease, leading to pain and functional disability. It is reported that polydeoxyribonucleotide (PDRN) is a suitable therapy for OA. However, the therapeutic mechanisms of PDRN in OA are not fully understood. To investigate the effect of PDRN in an <I>in vitro</I> model of OA, interleukin (IL)-1β or phosphate-buffered saline (PBS) was used to treat a human chondrocytic cell line in hypoxic conditions for 24 h (IL-1β group or control group). PDRN was then used to treat IL-1β group cells for 24 h (PDRN group). By Label-Based Human Antibody Array 1000, angiopoietin-2 (ANG-2), platelet-derived growth factor (PDGF), angiostatin, and endostatin, which were related to angiogenesis, were chosen for further validation studies. Quantitative real-time reverse transcription polymerase chain reaction and western blot analysis validated that the levels of PDGF and ANG-2, which were related to pro-angiogenesis, were significantly increased in the PDRN group compared with those in the control group or the IL-1β group. However, the levels of endostatin and angiostatin, which were related in anti-angiogenesis, were significantly decreased in the PDRN group compared with those in the control group or the IL-1β group. In the same manner, vascular endothelial growth factor, which was a mediator of angiogenesis, was significantly increased in the PDRN group compared with those in the control group or the IL-1β group. Furthermore, wound closure was significantly increased in the PDRN group compared with the control group or the IL-1β group by <I>in vitro</I> scratch assay. Moreover, PDRN decreased expression of metalloproteinase 13, as a catabolic factor for OA, but increased expression of aggrecan, which was an anabolic factor for OA. These data suggest that PDRN may promote angiogenesis and wound healing via down-regulation of catabolism and up-regulation of anabolism in an <I>in vitro</I> model of OA.</P>